Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

Good Day BIO: Why patents matter
Share
Good Day BIO Newsletter  •  January 20, 2023
Ending the week with BIO’s comments on the importance of the drug patent system, a look at biotech for carbon capture and removal, and a preview of Rachel King’s remarks at the Maryland Tech Council’s advocacy summit yesterday. (654 words, 3 minutes, 16 seconds)
Read More

Good Day BIO: 3 predictions for biotech in 2023
Share
Good Day BIO Newsletter  •  January 19, 2023
A biotech CEO has three predictions for the industry in 2023—read our Bio.News exclusive. Plus, BIO member Ginkgo Bioworks announced a new partnership to make a baby formula that can boost gut health. (662 words, 3 minutes, 18 seconds)
Read More

Good Day BIO: The true cost of a sickle cell cure
Share
Good Day BIO Newsletter  •  January 18, 2023
The New York Times has an important read on the true cost of breakthrough sickle cell therapies—and it’s not what you think. Plus, we’re all getting sticker shock with our breakfast lately—here’s how biotech can help. (647 words, 3 minutes, 14 seconds)
Read More

Membership Renewal Confirmation
Share
By filling out this form, you are indicating that your company is planning to renew it's 2023 BIO membership.  MktoForms2.loadForm("//go.bio.org", "490-EHZ-999", 3561);   MktoForms2.loadForm("//go.bio.org", "490-EHZ-999", 3749);
Read More

Good Day BIO: Kindergarten vaccination rates fall, again
Share
Good Day BIO Newsletter  •  January 17, 2023
Back from the long weekend with a look at the startling decline in kindergarten vaccination rates, and what they’re saying in Davos about biotech to solve our food and climate challenges. (650 words, 3 minutes, 15 seconds)
Read More

Good Day BIO: Cancer deaths have fallen 33%
Share
Good Day BIO Newsletter  •  January 13, 2023
Cancer deaths are falling—but so are kindergarten vaccination rates. Meanwhile, we’re celebrating 40 years of the Orphan Drug Act. (544 words, 2 minutes, 43 seconds)
Read More

Good Day BIO: Genomic sequencing goes global
Share
Good Day BIO Newsletter  •  January 12, 2023
We have early details on how the administration plans to roll out drug price controls—plus, a look at how COVID accelerated genomic sequencing worldwide and biotech champion Sen. Debbie Stabenow’s plans to retire. (679 words, 3 minutes, 23 seconds)
Read More

Good Day BIO: Net drug prices drop, but PBMs keep list prices up
Share
Good Day BIO Newsletter  •  January 11, 2023
New analysis tells the truth about drug prices, while new research highlights the need for biotech climate solutions. (708 words, 3 minutes, 32 seconds)
Read More

Good Day BIO: News from Mexico and JPM
Share
Good Day BIO Newsletter  •  January 10, 2023
Today, we have a readout from the North American Leaders’ Summit and what BIO said about Mexico’s plans to ban biotech corn, plus news from JPM and Capitol Hill. (730 words, 3 minutes, 39 seconds)
Read More

Groups Call on North American Leaders to Follow USMCA to Resolve Disputes, Grow Trade
Share
Press Release  •  January 9, 2023
The governments of Mexico, Canada and the United States should look to the framework in the U.S.-Mexico-Canada Agreement to continue growing the complementary trade and integrated markets throughout North America, agriculture-related associations said in a joint statement as the heads of the three nations gather today in Mexico City.   The groups encouraged the three governments to take advantage of relevant USMCA committees to align on best practices and resolve trade disputes such as Mexico’s proposed ban on some uses of biotech corn and other agricultural technologies.   “Through science- and risk-based policies that are efficient, predictable, and compliant with international obligations, North American markets can embrace technology that advances food security, agricultural sustainability and rural prosperity and foster a variety of cost-effective food choices for our consumers,” the groups wrote.   The three nations enjoy the largest trilateral agricultural trade relationship in the world. Agricultural trade in North American has grown from $7.8 billion to $67 billion, a 769.7% increase since the North American Free Trade Agreement took effect in 1994. USMCA replaced NAFTA in 2020 and provided “the world’s best framework” to turn the supply chain challenges of the last few years into an opportunity to further strengthen North American trade in agricultural products, the groups added.   “USMCA’s enhanced provisions for agricultural biotechnology set it apart from previous trade agreements,” said Beth Ellikidis, vice president of agriculture & environment at the Biotechnology Innovation Organization. “We are hopeful that the discussions taking place this week in Mexico City will affirm the importance of agricultural innovation for tackling climate change and food security and ensure our trading partners have functional regulatory systems that promote transparency and cooperation consistent with the agreement.”   “Any…
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 113
  • 114
  • 115
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO